Whilst this is based on only 40 female POLE ED heterozygotes and 17 female POLD1 heterozygotes, we conclude that female POLD1 ED heterozygotes in particular may be at an increased risk of developing breast cancer compared to the general population, but this is not proven. The gene discussed is POLD1; the disease is breast carcinoma.